Treatment of Coronavirus Disease 2019-Evidence-based or Personalized Medicine?

Clin Infect Dis. 2022 Jan 7;74(1):149-151. doi: 10.1093/cid/ciaa996.

Authors

Ferric C Fang¹, Robert T Schooley²

Affiliations

¹ Departments of Laboratory Medicine and Pathology, and Microbiology, University of Washington School of Medicine, Seattle, Washington, USA.
² Division of Infectious Diseases and Global Public Health, Center for Innovative Phage Applications and Therapeutics, University of California-San Diego, San Diego, California, USA.

No abstract available

Keywords: COVID-19; SARS-CoV-2; clinical trials; evidence-based medicine; personalized medicine.

Publication types

Editorial
Comment

MeSH terms

Antiviral Agents / therapeutic use
COVID-19*
Humans
Precision Medicine
SARS-CoV-2

Substances

Antiviral Agents